Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine.
Ontology highlight
ABSTRACT: Remarkable potency has been demonstrated for mRNA vaccines in reducing the global burden of the ongoing COVID-19 pandemic. An alternative form of the mRNA vaccine is the self-amplifying mRNA (sa-mRNA) vaccine, which encodes an alphavirus replicase that self-amplifies the full-length mRNA and SARS-CoV-2 spike (S) transgene. However, early-phase clinical trials of sa-mRNA COVID-19 vaccine candidates have questioned the potential of this platform to develop potent vaccines. We examined the immune gene response to a candidate sa-mRNA vaccine against COVID-19, ARCT-021, and compared our findings to the host response to other forms of vaccines. In blood samples from healthy volunteers that participated in a phase I/II clinical trial, greater induction of transcripts involved in Toll-like recepto
SUBMITTER: Ong EZ
PROVIDER: S-EPMC9703414 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA